EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 24 April 2024. Database contains 4821 unique substances/entries.
Filter the list
|
204-327-1
|
119-47-1
|
Repr. 1B |
yes |
||
|
204-419-1
|
120-71-8
|
Carc. 1B; Acute Tox. 4 |
yes |
||
|
219-943-6
|
2580-56-5
|
yes |
|||
|
273-688-5
|
69011-06-9
|
yes |
|||
|
257-175-3
|
51404-69-4
|
yes |
|||
|
201-173-7
|
79-06-1
|
Carc. 1B; Muta. 1B; Repr. 2; Acute Tox. 3; STOT RE 1; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
yes |
||
|
-
|
-
|
yes |
|||
|
287-476-5
|
85535-84-8
|
Carc. 2 |
yes |
||
|
281-985-6
|
84082-38-2
|
yes |
|||
|
307-451-5
|
97659-46-6
|
yes |
|||
|
283-930-1
|
84776-06-7
|
yes |
|||
|
287-504-6
|
85536-22-7
|
yes |
|||
|
701-376-5
|
1372804-76-6
|
yes |
|||
|
287-477-0
|
85535-85-9
|
Lact. |
yes |
||
|
283-931-7
|
84776-07-8
|
yes |
|||
|
285-195-2
|
85049-26-9
|
yes |
|||
|
272-924-4
|
68920-70-7
|
yes |
|||
|
263-004-3
|
61788-76-9
|
yes |
|||
|
603-801-9
|
134237-50-6
|
yes |
|||
|
604-314-4
|
142844-00-6
|
yes |
|||
|
700-242-3
|
62037-80-3
|
yes |
|||
|
232-143-1
|
7789-09-5
|
Ox. Sol. 2; Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Acute Tox. 4; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
221-470-5
|
3108-42-7
|
Carc. 2; Repr. 1B; Lact. |
yes |
||
|
269-511-6
|
68259-08-5
|
yes |
|||
|
-
|
4149-60-4
|
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1 |
yes |
||
|
223-320-4
|
3825-26-1
|
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1 |
yes |
||
|
204-371-1
|
120-12-7
|
yes |
|||
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330°C to 350°C (626°F to 662°F). It contains chiefly anthracene, carbazole and phenanthrene.
|
295-275-9
|
91995-15-2
|
Carc. 1B; Muta. 1B |
yes |
|
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290°C to 340°C (554°F to 644°F). It contains chiefly trinuclear aromatics and their dihydro derivatives.
|
295-278-5
|
91995-17-4
|
Carc. 1B; Muta. 1B |
yes |
|
|
The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.
|
292-603-2
|
90640-81-6
|
Carc. 1B; Muta. 1B |
yes |
|
|
The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.
|
292-604-8
|
90640-82-7
|
Carc. 1B; Muta. 1B |
yes |
|
|
A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300°C to 400°C (572°F to 752°F). Composed primarily of phenanthrene, anthracene and carbazole
|
292-602-7
|
90640-80-5
|
Carc. 1B |
yes |
|
|
231-901-9
|
7778-39-4
|
Carc. 1A; Acute Tox. 3 |
yes |
||
|
201-622-7
|
85-68-7
|
Repr. 1B |
yes |
||
|
200-280-6
|
56-55-3
|
Carc. 1B |
yes |
||
|
209-008-0
|
552-30-7
|
STOT SE 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
200-028-5
|
50-32-8
|
Carc. 1B; Muta. 1B; Repr. 1B; Skin Sens. 1 |
yes |
||
|
205-883-8
|
191-24-2
|
yes |
|||
|
205-916-6
|
207-08-9
|
Carc. 1B |
yes |
||
|
603-802-4
|
134237-51-7
|
yes |
|||
|
202-177-1
|
92-67-1
|
Carc. 1A; Acute Tox. 4 |
yes |
||
|
205-594-7
|
143-24-8
|
Repr. 1B |
yes |
||
|
204-211-0
|
117-81-7
|
Repr. 1B |
yes |
||
|
203-924-4
|
111-96-6
|
Flam. Liq. 3; Repr. 1B |
yes |
||
|
204-212-6
|
117-82-8
|
Repr. 1B |
yes |
||
|
214-604-9
|
1163-19-5
|
yes |
|||
|
200-268-0
|
56-35-9
|
yes |
|||
|
201-245-8
|
80-05-7
|
Repr. 1B; STOT SE 3; Eye Dam. 1; Skin Sens. 1 |
yes |
||
|
-
|
90568-23-3
|
yes |
|||
|
-
|
125022-34-6
|
yes |
|||